Lv1
40 积分 2024-10-23 加入
Molecular Heterogeneity, Standardized Assessment, and Therapeutic Advances of HER2 in Urothelial Carcinoma
4天前
已完结
The Nephrotoxicity of Checkpoint Inhibitors: A Mini Review
2个月前
已完结
The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer
3个月前
已完结
Lines of Therapy for Locally Advanced/Metastatic Urothelial Carcinoma: The New Paradigm
3个月前
已完结
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
4个月前
已完结
Efficacy, safety, and biomarker analysis of neoadjuvant avelumab/axitinib in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after nephrectomy (NeoAvAx)
4个月前
已关闭
Anlotinib-Induced Hypertension: Current Concepts and Future Prospects
5个月前
已完结
Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1
8个月前
已完结
In Vitro Kinetic Characterization of Axitinib Metabolism
8个月前
已完结
Exploration of the mechanism of anlotinib in reversing PD-1 immunotherapy resistance: insights from single-cell sequencing
8个月前
已完结
皖公网安备34019202002308
